RecruitingNCT07029581
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including IrvineSchizophreniaMedication studyAges 55–84
- Countries
- United States, France, Bulgaria, + 3 others
- Sponsor
- ACADIA Pharmaceuticals Inc.
RecruitingNCT07095465
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including IrvineSchizophreniaMedication studyAges 55–84
- Countries
- United States, France, Bulgaria, + 3 others
- Sponsor
- ACADIA Pharmaceuticals Inc.
RecruitingNCT04373317
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including Loma LindaSchizophreniaMedication studyAges 40+
- Countries
- United States
- Sponsor
- VA Office of Research and Development
RecruitingNCT07459270
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In ElâzığSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Elazığ Mental Health and Diseases Hospital
RecruitingNCT07459257
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In ElâzığSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Elazığ Mental Health and Diseases Hospital
RecruitingISRCTN52338801
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In United KingdomSchizophreniaResearch studyAges 18–100
- Countries
- United Kingdom
- Sponsor
- Greater Manchester Mental Health NHS Foundation Trust
RecruitingNCT07569471
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In Scarborough VillageSchizophreniaInterventional studyAges 18+
- Countries
- Canada
- Sponsor
- University of Toronto
RecruitingNCT06640803
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including Elk GroveSchizophreniaBehavioural studyAges 12–25
- Countries
- United States
- Sponsor
- University of California, Davis
RecruitingNCT06634446
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In ParisSchizophreniaDevice studyAges 16–35
- Countries
- France
- Sponsor
- Centre Hospitalier St Anne
RecruitingNCT07397975
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In ZurichSchizophreniaObservational studyAges 18–65
- Countries
- Switzerland, Czechia, Ireland, + 3 others
- Sponsor
- Philipp Homan
RecruitingNCT06778564
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including CambridgeSchizophreniaMedication studyAges 16–40
- Countries
- United Kingdom, Switzerland, Austria, + 6 others
- Sponsor
- University of Oxford
RecruitingNCT06036316
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In LaxouSchizophreniaBehavioural studyAges 16–55
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.